| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YFRNE.2020.100857 |
| P698 | PubMed publication ID | 32781194 |
| P2093 | author name string | Hui Chen | |
| Nan Wang | |||
| Chenju Yi | |||
| Xiaomin Huang | |||
| Zhangsen Huang | |||
| Yixun Su | |||
| Lik-Wei Wong | |||
| P2860 | cites work | Free testosterone and risk for Alzheimer disease in older men | Q22306167 |
| Pericytes Control Key Neurovascular Functions and Neuronal Phenotype in the Adult Brain and during Brain Aging | Q24600644 | ||
| Pericytes are required for blood-brain barrier integrity during embryogenesis | Q24627396 | ||
| A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. | Q24631193 | ||
| CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer | Q24642646 | ||
| Occludin: a novel integral membrane protein localizing at tight junctions | Q24657666 | ||
| Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells | Q24679401 | ||
| Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration | Q24682572 | ||
| Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells | Q24682677 | ||
| Interstitial cells subjacent to the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to development of Alzheimer's disease-related cytoskeletal changes | Q48498335 | ||
| Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis | Q48504308 | ||
| Effect of estrogen on the expression of occludin in ovariectomized mouse brain | Q48571905 | ||
| Ultrastructural studies of the cells forming amyloid in the cortical vessel wall in Alzheimer's disease | Q48588831 | ||
| GLUT-1 expression in the cerebra of patients with Alzheimer's disease | Q48589517 | ||
| The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence | Q48797548 | ||
| Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer's disease | Q48918033 | ||
| Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor | Q48933977 | ||
| Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation | Q48960635 | ||
| Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. | Q50720019 | ||
| Blood-brain barrier P-glycoprotein function in Alzheimer's disease. | Q50778486 | ||
| Somatostatin preserved blood brain barrier against cytokine induced alterations: possible role in multiple sclerosis. | Q50904768 | ||
| Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study. | Q50917440 | ||
| Prediction of Alzheimer's disease using midregional proadrenomedullin and midregional proatrial natriuretic peptide: a retrospective analysis of 134 patients with mild cognitive impairment. | Q51024714 | ||
| Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. | Q51559492 | ||
| A rapid method for cross-species quantitation of apolipoproteins A1, B48 and B100 in plasma by ultra-performance liquid chromatography/tandem mass spectrometry. | Q51762935 | ||
| Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study. | Q51952380 | ||
| Somatostatin Maintains Permeability and Integrity of Blood-Brain Barrier in β-Amyloid Induced Toxicity. | Q52691950 | ||
| Ultrastructural studies of the cells forming amyloid fibers in classical plaques. | Q53187413 | ||
| Characterization of dementia and Alzheimer's disease in an older population: updated incidence and life expectancy with and without dementia. | Q53354784 | ||
| Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes. | Q54378715 | ||
| Deciphering the Astrocyte Reaction in Alzheimer's Disease. | Q55364689 | ||
| Blood-Brain Barrier: From Physiology to Disease and Back | Q57023036 | ||
| Pericytes and the blood–brain barrier: recent advances and implications for the delivery of CNS therapy | Q57083860 | ||
| Drug transport across the blood-brain barrier | Q57677287 | ||
| Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-β42 by LRP1-dependent apolipoprotein E isoform-specific mechanism | Q57810850 | ||
| Targeting Apolipoprotein E for Alzheimer's Disease: An Industry Perspective. | Q64934178 | ||
| The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases | Q71674774 | ||
| Neutral amino acid transport characterization of isolated luminal and abluminal membranes of the blood-brain barrier | Q72350320 | ||
| Production of adrenomedullin in human vascular endothelial cells | Q73338033 | ||
| Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view | Q73489985 | ||
| Astrocytes: a cellular player in Abeta clearance and degradation | Q73755875 | ||
| Bidirectional control of arteriole diameter by astrocytes | Q83271897 | ||
| Aquaporin-4 mediates astrocyte response to β-amyloid | Q83514237 | ||
| Capillary and arteriolar pericytes attract innate leukocytes exiting through venules and 'instruct' them with pattern-recognition and motility programs | Q85522762 | ||
| Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy | Q88295850 | ||
| CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology | Q90107242 | ||
| Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction | Q91046010 | ||
| 3K3A-activated protein C blocks amyloidogenic BACE1 pathway and improves functional outcome in mice | Q91061889 | ||
| Proteomic Quantification of Human Blood-Brain Barrier SLC and ABC Transporters in Healthy Individuals and Dementia Patients | Q91418279 | ||
| Effects of Androgens on the Amyloid-β Protein in Alzheimer's Disease | Q91445512 | ||
| Development and Cell Biology of the Blood-Brain Barrier | Q91829745 | ||
| Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk | Q92090764 | ||
| Dual microglia effects on blood brain barrier permeability induced by systemic inflammation | Q92163458 | ||
| The blood-brain barrier as an endocrine tissue | Q92283223 | ||
| A vicious cycle of β amyloid-dependent neuronal hyperactivation | Q92508449 | ||
| Astrocyte-derived fatty acid-binding protein 7 protects blood-brain barrier integrity through a caveolin-1/MMP signaling pathway following traumatic brain injury | Q92902485 | ||
| Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss | Q93001092 | ||
| Higher rates of decline for women and apolipoprotein E epsilon4 carriers | Q37487612 | ||
| Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women | Q37518052 | ||
| Phenotypic heterogeneity and plasticity of isocortical and hippocampal astrocytes in the human brain | Q37555027 | ||
| Astrocyte barriers to neurotoxic inflammation | Q37597818 | ||
| Neurochemistry of the paraventricular nucleus of the hypothalamus: implications for cardiovascular regulation | Q37602795 | ||
| Pericyte loss influences Alzheimer-like neurodegeneration in mice. | Q37623577 | ||
| M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination | Q37687158 | ||
| The molecular basis of the blood brain barrier differentiation and maintenance. Is it still a mystery? | Q37822008 | ||
| Nitric oxide as key mediator of neuron-to-neuron and endothelia-to-glia communication involved in the neuroendocrine control of reproduction | Q37845068 | ||
| Brain microvascular pericytes in health and disease | Q37886829 | ||
| The role of pericytes in angiogenesis | Q37895203 | ||
| Nitric oxide: A pleiotropic signal in the nervous system | Q37946840 | ||
| Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? | Q38099671 | ||
| Developmental maturation of astrocytes and pathogenesis of neurodevelopmental disorders | Q38132479 | ||
| Glial influence on the blood brain barrier. | Q38152380 | ||
| Pericytes: brain-immune interface modulators | Q38181071 | ||
| The role of pericytes in neurovascular unit remodeling in brain disorders | Q38205364 | ||
| Clearance of beta-amyloid in the brain | Q38259852 | ||
| Astrocytes in physiological aging and Alzheimer's disease | Q38321554 | ||
| Targeted delivery of protein and gene medicines through the blood-brain barrier | Q38351122 | ||
| Innate immunity in Alzheimer's disease | Q38358574 | ||
| Impact of sex and APOE4 on cerebral amyloid angiopathy in Alzheimer's disease | Q38407944 | ||
| Adrenomedullin Expression in Alzheimer's Brain | Q38753523 | ||
| Brain pericytes serve as microglia-generating multipotent vascular stem cells following ischemic stroke | Q38839908 | ||
| Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity. | Q38844684 | ||
| Pericytes of the neurovascular unit: key functions and signaling pathways. | Q38844788 | ||
| The Prevalence and Incidence of Dementia Due to Alzheimer's Disease: a Systematic Review and Meta-Analysis | Q38852543 | ||
| The blood-brain barrier in Alzheimer's disease. | Q38899745 | ||
| Chronic depletion of gonadal testosterone leads to blood-brain barrier dysfunction and inflammation in male mice. | Q38931182 | ||
| Pre-treatment of 17β-estradiol Attenuates Cerebral-Ischemia-Induced Blood-Brain Barrier Disruption in Aged Rats: Involvement of Antioxidant Signaling | Q38962020 | ||
| Androgen deprivation therapy for prostate cancer and dementia risk: a systematic review and meta-analysis | Q39204570 | ||
| Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease | Q39313671 | ||
| Minocycline selectively inhibits M1 polarization of microglia | Q39496127 | ||
| Astroglial connexin43 contributes to neuronal suffering in a mouse model of Alzheimer's disease | Q39621152 | ||
| Incidence of Alzheimer disease in a biracial urban community: relation to apolipoprotein E allele status | Q39641831 | ||
| Racial Differences in the Association Between Apolipoprotein E Risk Alleles and Overall and Total Cardiovascular Mortality Over 18 Years. | Q40045522 | ||
| Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa | Q40083223 | ||
| Preeclampsia and cognitive impairment later in life | Q40283154 | ||
| GLT-1 loss accelerates cognitive deficit onset in an Alzheimer's disease animal model | Q40327935 | ||
| LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. | Q40528558 | ||
| Estrogen protects the blood-brain barrier from inflammation-induced disruption and increased lymphocyte trafficking | Q40592557 | ||
| A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. | Q40657503 | ||
| Estradiol attenuation of beta-amyloid-induced toxicity: a comparison o. | Q40796617 | ||
| Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain | Q40917096 | ||
| Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils | Q41173971 | ||
| Brain vascular pericytes following ischemia have multipotential stem cell activity to differentiate into neural and vascular lineage cells | Q41397599 | ||
| TGFβ signalling plays an important role in IL4-induced alternative activation of microglia | Q41508902 | ||
| Test of the 'glymphatic' hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma. | Q41578156 | ||
| Minocycline, a microglial inhibitor, blocks spinal CCL2-induced heat hyperalgesia and augmentation of glutamatergic transmission in substantia gelatinosa neurons | Q41786321 | ||
| P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model | Q41844698 | ||
| Astrocytic LRP1 Mediates Brain Aβ Clearance and Impacts Amyloid Deposition. | Q42291622 | ||
| Foxf2 Is Required for Brain Pericyte Differentiation and Development and Maintenance of the Blood-Brain Barrier | Q42479040 | ||
| Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation. | Q42503747 | ||
| Aquaporin and blood brain barrier | Q42532303 | ||
| Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells | Q42645477 | ||
| ABC efflux transporters in brain vasculature of Alzheimer's subjects | Q42930763 | ||
| Pharmacological shift of the ambiguous nitric oxide action from neurotoxicity to cyclic GMP-mediated protection | Q43082138 | ||
| apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain | Q43243545 | ||
| Lipopolysaccharide-activated microglia induce dysfunction of the blood-brain barrier in rat microvascular endothelial cells co-cultured with microglia | Q43281525 | ||
| Modulation of A(beta) peptides by estrogen in mouse models | Q43858172 | ||
| Genome-wide association study on plasma levels of midregional-proadrenomedullin and C-terminal-pro-endothelin-1. | Q44378882 | ||
| Protein misfolding, congophilia, oligomerization, and defective amyloid processing in preeclampsia. | Q44381844 | ||
| Relationship between testosterone, sex hormone binding globulin and plasma amyloid beta peptide 40 in older men with subjective memory loss or dementia. | Q44659757 | ||
| Low androgenization index in elderly women and elderly men with Alzheimer's disease | Q44743474 | ||
| Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression. | Q44751997 | ||
| Is the risk of developing Alzheimer's disease greater for women than for men? | Q44844730 | ||
| 17beta-estradiol differentially regulates blood-brain barrier permeability in young and aging female rats. | Q45096375 | ||
| Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. | Q45180802 | ||
| Estrogen therapy fails to alter amyloid deposition in the PDAPP model of Alzheimer's disease | Q45282678 | ||
| Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice | Q45340447 | ||
| Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma | Q45345831 | ||
| Chronic ceftriaxone treatment rescues hippocampal memory deficit in AQP4 knockout mice via activation of GLT-1. | Q46214907 | ||
| Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease | Q46372282 | ||
| Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. | Q46675546 | ||
| Morphologic association between microglia and senile plaque amyloid in Alzheimer's disease | Q46691404 | ||
| A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease | Q47107905 | ||
| The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease | Q47257826 | ||
| Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease | Q47552349 | ||
| Matrix metalloproteinases expressed by astrocytes mediate extracellular amyloid-beta peptide catabolism. | Q47587456 | ||
| Blood-Brain Barrier Leakage in Patients with Early Alzheimer Disease | Q47662024 | ||
| Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders | Q47707801 | ||
| Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer's Disease | Q47863897 | ||
| Epigallocatechin gallate induces extracellular degradation of amyloid β-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways | Q47900717 | ||
| The effects of 17β-estradiol on blood brain barrier integrity in the absence of the estrogen receptor alpha; an in-vitro model | Q47958892 | ||
| P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer's disease: preliminary observations | Q48087813 | ||
| Astrocyte and Alzheimer's disease | Q48148540 | ||
| Cyclic guanosine monophosphate signalling pathway plays a role in neural cell adhesion molecule-mediated neurite outgrowth and survival | Q48284604 | ||
| Understanding spatial and temporal patterning of astrocyte calcium transients via interactions between network transport and extracellular diffusion | Q48386542 | ||
| Characteristics of aquaporin expression surrounding senile plaques and cerebral amyloid angiopathy in Alzheimer disease | Q48437532 | ||
| Hormone therapy and risk of Alzheimer disease: a critical time | Q48453003 | ||
| Mechanisms of Aβ Clearance and Degradation by Glial Cells | Q26741609 | ||
| Neuropathological alterations in Alzheimer disease | Q27003314 | ||
| The glia doctrine: addressing the role of glial cells in healthy brain ageing | Q27004112 | ||
| Emerging roles of pericytes in the regulation of the neurovascular unit in health and disease | Q27011505 | ||
| The genetics of Alzheimer disease | Q27026166 | ||
| Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits | Q27301321 | ||
| Distinct Contributions of Astrocytes and Pericytes to Neuroinflammation Identified in a 3D Human Blood-Brain Barrier on a Chip | Q27319805 | ||
| Endothelial LRP1 transports amyloid-β(1-42) across the blood-brain barrier | Q27332086 | ||
| Astrocyte-endothelial interactions at the blood-brain barrier | Q28131675 | ||
| Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice | Q28203769 | ||
| Physiology of microglia | Q29547414 | ||
| Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders | Q29615839 | ||
| Pericytes regulate the blood-brain barrier | Q29615840 | ||
| The blood-brain barrier in health and chronic neurodegenerative disorders | Q29616411 | ||
| Endothelial/pericyte interactions | Q29619802 | ||
| Microglia: a sensor for pathological events in the CNS | Q29620556 | ||
| Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance | Q30090186 | ||
| Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction | Q30496577 | ||
| Endothelial-derived PDGF-BB and HB-EGF coordinately regulate pericyte recruitment during vasculogenic tube assembly and stabilization | Q30497541 | ||
| Are sex and educational level independent predictors of dementia and Alzheimer's disease? Incidence data from the PAQUID project | Q30559409 | ||
| Purification and Characterization of Progenitor and Mature Human Astrocytes Reveals Transcriptional and Functional Differences with Mouse | Q30696856 | ||
| Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging | Q30829062 | ||
| NADPH oxidase as a therapeutic target in Alzheimer's disease | Q30855129 | ||
| Macrophage depletion diminishes lesion size and severity in experimental choroidal neovascularization | Q30969814 | ||
| Brain imaging of neurovascular dysfunction in Alzheimer's disease | Q31066988 | ||
| In situ localization of P-glycoprotein (ABCB1) in human and rat brain | Q33248008 | ||
| Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system | Q33262322 | ||
| Central nervous system pericytes in health and disease | Q33609398 | ||
| Plastic roles of pericytes in the blood-retinal barrier. | Q33716453 | ||
| Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. | Q33717326 | ||
| Cellular mechanisms of CNS pericytes | Q33861779 | ||
| Gender and incidence of dementia in the Framingham Heart Study from mid-adult life | Q33882491 | ||
| Clearance of Alzheimer's amyloid-ss(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier | Q33928434 | ||
| Fine structural localization of a blood-brain barrier to exogenous peroxidase | Q34054533 | ||
| The intersection of amyloid beta and tau at synapses in Alzheimer's disease | Q34054680 | ||
| Effect of prenatal glucocorticoids on cerebral vasculature of the developing brain | Q34059834 | ||
| Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's | Q36536213 | ||
| Accelerated pericyte degeneration and blood-brain barrier breakdown in apolipoprotein E4 carriers with Alzheimer's disease. | Q36593210 | ||
| Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias | Q36623399 | ||
| Innate immunity receptor CD36 promotes cerebral amyloid angiopathy | Q36637524 | ||
| What is the role of astrocyte calcium in neurophysiology? | Q36758589 | ||
| Safety and tolerability of BAN2401--a clinical study in Alzheimer's disease with a protofibril selective Aβ antibody | Q36769531 | ||
| Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease | Q36773984 | ||
| Insulin-degrading enzyme secretion from astrocytes is mediated by an autophagy-based unconventional secretory pathway in Alzheimer disease. | Q36862693 | ||
| New therapeutic targets in the neurovascular pathway in Alzheimer's disease | Q36876341 | ||
| Bapineuzumab for mild to moderate Alzheimer's disease in two global, randomized, phase 3 trials | Q36899566 | ||
| Guarding the blood-brain barrier: a role for estrogen in the etiology of neurodegenerative disease. | Q36914297 | ||
| Heat shock proteins and amateur chaperones in amyloid-Beta accumulation and clearance in Alzheimer's disease | Q36961152 | ||
| Alzheimer disease in the United States (2010-2050) estimated using the 2010 census | Q37035610 | ||
| Reduction of microglial activity in a model of multiple sclerosis by dipyridamole. | Q37048242 | ||
| Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. | Q37216153 | ||
| Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer's disease | Q37220551 | ||
| Amyloid-β1-42 slows clearance of synaptically released glutamate by mislocalizing astrocytic GLT-1. | Q37399976 | ||
| A Role for P-Glycoprotein in Clearance of Alzheimer Amyloid β -Peptide from the Brain | Q37403948 | ||
| CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. | Q37424811 | ||
| Role of the CNS microvascular pericyte in the blood-brain barrier | Q34067528 | ||
| Testosterone deficiency accelerates neuronal and vascular aging of SAMP8 mice: protective role of eNOS and SIRT1 | Q34125136 | ||
| A de novo nonsense PDGFB mutation causing idiopathic basal ganglia calcification with laryngeal dystonia | Q34215715 | ||
| The blood-brain barrier in health and disease | Q34320420 | ||
| Gene regulation and DNA damage in the ageing human brain | Q34326236 | ||
| The ABCs of membrane transporters in health and disease (SLC series): introduction | Q34333686 | ||
| What is a pericyte? | Q34504912 | ||
| Microvascular injury and blood-brain barrier leakage in Alzheimer's disease | Q34539460 | ||
| The blood-brain barrier and cancer: transporters, treatment, and Trojan horses | Q34577796 | ||
| Nitric oxide and nitroxidative stress in Alzheimer's disease. | Q34579767 | ||
| Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury | Q34614529 | ||
| Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause | Q34673158 | ||
| Complex phenotype of mice lacking occludin, a component of tight junction strands. | Q34781594 | ||
| The blood-brain barrier | Q34931170 | ||
| Blood-brain barrier breakdown in the aging human hippocampus | Q35151019 | ||
| Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy | Q35158609 | ||
| Aquaporin expression in the brains of patients with or without cerebral amyloid angiopathy | Q35162332 | ||
| Pericyte structure and distribution in the cerebral cortex revealed by high-resolution imaging of transgenic mice | Q35775199 | ||
| The neurovascular unit, matrix proteases, and innate inflammation | Q35990775 | ||
| Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA. | Q36054559 | ||
| Sex and gender differences in health. Science & Society Series on Sex and Science | Q36073394 | ||
| Neurovascular mechanisms of Alzheimer's neurodegeneration | Q36088588 | ||
| Beyond neurovascular coupling, role of astrocytes in the regulation of vascular tone | Q36118847 | ||
| Marked gender differences in progression of mild cognitive impairment over 8 years | Q36120187 | ||
| Deletion of astroglial connexins weakens the blood-brain barrier. | Q36170335 | ||
| Aβ1-42 reduces P-glycoprotein in the blood-brain barrier through RAGE-NF-κB signaling | Q36179624 | ||
| Statins induce insulin-degrading enzyme secretion from astrocytes via an autophagy-based unconventional secretory pathway | Q36235102 | ||
| T-cells in Alzheimer's disease. | Q36295994 | ||
| Establishment and Dysfunction of the Blood-Brain Barrier | Q36306827 | ||
| Neurovascular dysfunction and faulty amyloid β-peptide clearance in Alzheimer disease | Q36330297 | ||
| Expanding the definition of the blood-brain barrier to protein | Q36384843 | ||
| Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase | Q36403694 | ||
| GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration | Q36526013 | ||
| P921 | main subject | blood–brain barrier | Q221694 |
| P304 | page(s) | 100857 | |
| P577 | publication date | 2020-08-08 | |
| P1433 | published in | Frontiers in Neuroendocrinology | Q15716620 |
| P1476 | title | Blood-brain barrier integrity in the pathogenesis of Alzheimer's disease |
Search more.